INFOS !
  • NEW ADDRESS: The management team of ERN-EYE is moving! Starting from March 19, you can find us at 1 Rue Eugène Boeckel, 67000 Strasbourg.

Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Clinical trials

What’s a clinical trial?

Clinical research refers to all studies conducted on humans (healthy or sick individuals). It primarily focuses on advancing knowledge of diseases, developing new treatments or medical devices, diagnostic methods to ensure better patient care. Highly regulated, it adheres to a specific study protocol and is only carried out under certain conditions:

  1. The purpose is to increase medical knowledge.
  2. It is conducted by competent individuals.
  3. All measures are taken to protect the individuals participating in the research.
  4. Regulatory authorizations have been obtained, and all necessary legal and ethical steps have been taken.
  5. Obtaining the consent of the individuals participating in the research (Legifrance: Article L1121-1 of the Public Health Code).

There are two main types of clinical studies:

  1. Observational studies (e.g., cohort studies, epidemiology).
  2. Interventional studies or clinical trials.

The icons colors are as follow:

Black: completed trials
Grey: unknown status
Blue: active and recruiting trials
Orange: active and not recruting trials

NCT05809635 Recruiting, Active

Study of BEST1 Vitelliform Macular Dystrophy

Observational
NCT06591806 Recruiting, Active

An Observational Study in Children and Adults With Stargardt Disease

Observational
NCT06140329 Recruiting, Active

Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation

Observational
NCT03349801 Active, Not recruiting

MACUSTAR

Observational
NCT06591793 Recruiting, Active

Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa

Interventional
2020-005875-10 Completed

BUTTERFLEYE NEXT

Interventional
NCT06176352 Recruiting, Active

A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia

Interventional
NCT05870566 Recruiting, Active

Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision]

Interventional
Résultats 1 à 10 sur 193
Dernière page